MECHANISMS OF INDUCTION OF PRIMARY VIRUS-SPECIFIC CYTOTOXIC LYMPHOCYTE-T RESPONSES

被引:58
作者
DEBRUIJN, MLH
NIELAND, JD
SCHUMACHER, TNM
PLOEGH, HL
KAST, WM
MELIEF, CJM
机构
[1] ACAD HOSP LEIDEN, DIV IMMUNOHAEMATOL & BLOODBANK, 2333 AA LEIDEN, NETHERLANDS
[2] NETHERLANDS CANC INST, DIV IMMUNOL, 1066 CX AMSTERDAM, NETHERLANDS
[3] NETHERLANDS CANC INST, DIV CELLULAR BIOCHEM, 1066 CX AMSTERDAM, NETHERLANDS
关键词
D O I
10.1002/eji.1830221137
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have investigated the ability of various antigen-presenting cell (APC) types to induce primary anti-viral cytotoxic T lymphocyte (CTL) responses by single in vitro stimulation. Of these APC types, only dendritic cells (DC) and RMA-S lymphoma cells could induce primary CTL responses, but by divergent mechanisms. DC were capable of generating primary virus-specific CTL, either by presenting viral peptide or processed infectious virus. In contrast, RMA-S cells could not present endogenous antigen, e.g. after virus infection, but this cell line very efficiently presented exogenous viral peptides to induce primary virus-specific CTL in vitro. Spleen cells, lipopolysaccharide-induced B cell blasts or the non-mutated RMA cells did not have the ability to trigger unprimed T cells by single in vitro stimulation.We have investigated several characteristics important for primary CTL response induction by DC and RMA-S cells (summarized in Fig. 6). Primary CTL response induction by DC or RMA-S cells was blocked by anti-LFA-1 or anti-CD8 monoclonal antibodies (mAb). DC rapidly aggregated with unprimed T cells, which was independent of LFA-1 and CD8 molecules. RMA-S cells did not form conjugates with unprimed T cells. Despite their abundant major histocompatibility complex (MHC) class I cell-surface expression, DC did not bind much exogenously added viral peptide. In contrast, the MHC class I molecules on RMA-S cells bound a large quantity of exogenously administered peptide, Powerful adhesion by DC and high expression of relevant MHC/peptide complexes on RMA-S cells are important features in the initial contact with unprimed T lymphocytes. In a later stage of contact, both DC and RMA-S cells activate LFA-1 (and CD8) molecules at the T cell surface to strengthen and maintain the contact between T cell and APC.
引用
收藏
页码:3013 / 3020
页数:8
相关论文
共 51 条
[1]   KINASES AND PHOSPHATASES IN T-CELL ACTIVATION [J].
ALEXANDER, DR ;
CANTRELL, DA .
IMMUNOLOGY TODAY, 1989, 10 (06) :200-205
[2]   ABOLITION OF SPECIFIC IMMUNE-RESPONSE DEFECT BY IMMUNIZATION WITH DENDRITIC CELLS [J].
BOOG, CJP ;
KAST, WM ;
TIMMERS, HTM ;
BOES, J ;
DEWAAL, LP ;
MELIEF, CJM .
NATURE, 1985, 318 (6041) :59-62
[3]  
BOOG CJP, 1988, J IMMUNOL, V140, P3331
[4]   SPECIFIC IMMUNE-RESPONSES RESTORED BY ALTERATION IN CARBOHYDRATE CHAINS OF SURFACE MOLECULES ON ANTIGEN-PRESENTING CELLS [J].
BOOG, CJP ;
NEEFJES, JJ ;
BOES, J ;
PLOEGH, HL ;
MELIEF, CJM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (03) :537-542
[5]   STIMULATION WITH DENDRITIC CELLS DECREASES OR OBVIATES THE CD4+ HELPER-CELL REQUIREMENT IN CYTO-TOXIC LYMPHOCYTE-T RESPONSES [J].
BOOG, CJP ;
BOES, J ;
MELIEF, CJM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (02) :219-223
[6]   RECOGNITION BY CD8 ON CYTOTOXIC LYMPHOCYTES-T IS ABLATED BY SEVERAL SUBSTITUTIONS IN THE CLASS-I ALPHA-3 DOMAIN - CD8 AND THE T-CELL RECEPTOR RECOGNIZE THE SAME CLASS-I MOLECULE [J].
CONNOLLY, JM ;
HANSEN, TH ;
INGOLD, AL ;
POTTER, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2137-2141
[7]   THE CELL-SURFACE OF MOUSE DENDRITIC CELLS - FACS ANALYSES OF DENDRITIC CELLS FROM DIFFERENT TISSUES INCLUDING THYMUS [J].
CROWLEY, M ;
INABA, K ;
WITMERPACK, M ;
STEINMAN, RM .
CELLULAR IMMUNOLOGY, 1989, 118 (01) :108-125
[8]   PEPTIDE LOADING OF EMPTY MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES ON RMA-S CELLS ALLOWS THE INDUCTION OF PRIMARY CYTOTOXIC LYMPHOCYTE-T RESPONSES [J].
DEBRUIJN, MLH ;
SCHUMACHER, TNM ;
NIELAND, JD ;
PLOEGH, HL ;
KAST, WM ;
MELIEF, CJM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (12) :2963-2970
[9]  
DEWAAL LP, 1983, J IMMUNOL, V130, P1090
[10]  
EICHMANN K, 1991, J IMMUNOL, V147, P2075